Biopix-T Gets CE Mark for COVID-19 Test and Molecular Diagnostic Platform

Biopix DNA Technology (Biopix-T) has received a CE mark for its COVID-19 test, COV19 qcLAMP, and for the diagnostic platform it runs on.

The portable molecular diagnostic system, dubbed Pebble qcLAMP, uses polymerase chain-reaction (PCR) technology and can be used at the point of care, the company said.

The COVID-19 kit, which uses saliva samples and delivers results within 30 minutes, was developed at the Institute of Molecular Biology and Biotechnology in Crete.